Skip to main content

Advertisement

Featured series: "Bioelectronic medicine: engineering advances, physiological insights, and translational applications"

New Content ItemOur new thematic series, guest edited by Stavros Zanos, Timir Datta-Chaudhuri, Vasiliki Giagka, Loren Rieth, and Theodoros Zanos, is now open for submissions. Our field has grown significantly in the last decade.  It is an intrinsically multidisciplinary field and therefore advances require collaboration across diverse areas of expertise. For this series we would like to invite original contributions and reviews in the following areas: novel neural interfaces; methods, systems, and applications of targeted neuromodulation; advances in bioelectronic data analytics; new implantable bioelectronic devices; and translation of bioelectronic therapies. Please see here for more details.

Announcing our new article types

Our journal is proud to offer four new article types, ready for submissions! 

  • Mini-reviews, which provide a concise summary of a specific research topic or field relevant to our scope.
  • Perspectives, which grants the opportunity to write about the current state and recent developments of a research field or topic within our scope and point to associated challenges and future directions.
  • Opinions, written with a specific focus on a previously published article which has had a major impact on the field.
  • Commentaries, invited pieces which provide further discussion on a primary research manuscript.

Please see our Submission Guidelines page for more.

Reviewers of the quarter

Bioelectronic Medicine would like to recognize the efforts of the following peer reviewers, for their excellent service during the first quarter of 2019. These individuals have all exceeded expectations as far as acceptance rate, the number of completed reviews, and timeliness. The journal cannot succeed without its peer reviewers, and we thank these hard-working members of our network:

Bruno Bonaz
Yao-Chuan Chang
Imanuel Lerman

Aims and scope

Bioelectronic Medicine provides a necessary and specific publication platform for the growing field of Bioelectronic Medicine. We are primarily interested in publishing insights into the regulatory functions of the nervous system and related neuromodulation technologies that affect specific molecular mechanisms with the goal of developing new approaches in disease diagnosis and treatment. We will also feature bioelectronic approaches for monitoring and controlling specific biological processes and functions with relevance to this evolving, multidisciplinary field. Read more

About the Editor

New Content ItemDr Kevin J Tracey is president of The Feinstein Institutes for Medical Research, and professor of Molecular Medicine and Neurosurgery at the Zucker School of Medicine. He is a leader in the study of the molecular basis of inflammation. He and his colleagues identified the neural mechanism for controlling the immunological responses to infection and injury, and developed devices to replace anti-inflammatory drugs in clinical trials of rheumatoid arthritis, a new field termed bioelectronic medicine. The recipient of numerous awards and honors, including an honorary degree from the Karolinska Institutet, Dr Tracey is a fellow in the American Association for the Advancement of Science, and a member in the American Society for Clinical Investigation, and the Association of American Physicians. He is co-founder and Councilor of the Global Sepsis Alliance.

Dr Tracey graduated summa cum laude from Boston College, majoring in chemistry, and received his MD from Boston University. He trained in neurosurgery at the New York Hospital/Cornell University Medical Center, and was guest investigator at The Rockefeller University. Since 1992, he has directed the Laboratory of Biomedical Science in Manhasset, NY, where in 2005 he was appointed president of the Feinstein Institutes. Dr Tracey delivers lectures nationally and internationally on inflammation, sepsis, the neuroscience of immunity, and bioelectronic medicine. He is the author of Fatal Sequence (Dana Press) and more than 370 scientific papers.

About Feinstein Institutes for Medical Research

New Content ItemBioelectronic Medicine is published in partnership with The Feinstein Institutes for Medical Research. As the research arm of Northwell Health, the largest healthcare provider in New York, it is home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities. The Feinstein Institutes include 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how the Feinstein Institutes empower imagination and pioneers discovery, visit FeinsteinInstitute.org.

Articles

  1. Content type: Research article

      |  

    Authors: Harold A. Silverman, Andrew Stiegler, Téa Tsaava, Justin Newman, Benjamin E. Steinberg, Emily Battinelli Masi, Sergio Robbiati, Chad Bouton, Patricio T. Huerta, Sangeeta S. Chavan and Kevin J. Tracey

Most accessed articles RSS

View all articles

Pre-submission inquiries

The Editors of Bioelectronic Medicine welcome authors to send any pre-submission inquiries they might have here. We ask that you please include “Pre-submission inquiry” in the subject line of your email and that you include the title and abstract of your proposed submission within the message. Our Editors will do their best to respond to you in a timely manner.

Molecular Medicine

New Content ItemIf you enjoy Bioelectronic Medicine, we invite you to visit Feinstein’s flagship journal, Molecular Medicine (published by BMC). Published for nearly a quarter of a century and fully indexed, Molecular Medicine focuses on recent insights into the molecular mechanisms of disease pathogenesis, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. You will find material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes, as well as content which describes the clinical implications of these findings, at a level approachable by our broad audience.

Advertisement

Annual Journal Metrics

  • Speed
    40 days to first decision for reviewed manuscripts only
    40 days to first decision for all manuscripts
    74 days from submission to acceptance
    24 days from acceptance to publication

    Usage 
    17,978 downloads
    177 mentions

Advertisement